Am J Addict. 2006 Jan-Feb;15(1):76-84.

A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal.

Mariani JJ, Rosenthal RN, Tross S, Singh P, Anand OP.

Source

Department of Psychiatry, Division on Substance Abuse, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA. jm2330@columbia.edu

Abstract

Gabapentin was compared with phenobarbital for the treatment of alcohol withdrawal in a randomized, open-label, controlled trial in 27 inpatients. There were no significant differences in the proportion of treatment completers between treatment groups or the proportion of patients in each group requiring rescue medication for breakthrough signs and symptoms of alcohol withdrawal. There were no significant treatment differences in withdrawal symptoms or psychological distress, nor were there serious adverse events. These findings suggest that gabapentin may be as effective as phenobarbital in the treatment of alcohol withdrawal. Given gabapentin's favorable pharmacokinetic profile, further study of its effectiveness in treating alcohol withdrawal is warranted.

PMID:: 16449096; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. [Alcohol Clin Exp Res. 2009]
A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.
Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, Randall CL. Alcohol Clin Exp Res. 2009 Sep; 33(9):1582-8. Epub 2009 May 26.
A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. [Alcohol Clin Exp Res. 2007]
A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm.
Myrick H, Anton R, Voronin K, Wang W, Henderson S. Alcohol Clin Exp Res. 2007 Feb; 31(2):221-7.
Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. [J Clin Psychiatry. 2007]
Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial.
Furieri FA, Nakamura-Palacios EM. J Clin Psychiatry. 2007 Nov; 68(11):1691-700.
Review Treatment of alcohol withdrawal syndrome with carbamazepine, gabapentin, and nitrous oxide. [Am J Health Syst Pharm. 2008]
Review Treatment of alcohol withdrawal syndrome with carbamazepine, gabapentin, and nitrous oxide.
Prince V, Turpin KR. Am J Health Syst Pharm. 2008 Jun 1; 65(11):1039-47.
Review Novel anticonvulsants in the treatment of alcoholism. [Expert Opin Investig Drugs. 2005]
Review Novel anticonvulsants in the treatment of alcoholism.
Book SW, Myrick H. Expert Opin Investig Drugs. 2005 Apr; 14(4):371-6.

See reviews... See all...

Cited by 3 PubMed Central articles

A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. [Alcohol Clin Exp Res. 2008]
A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia.
Brower KJ, Myra Kim H, Strobbe S, Karam-Hage MA, Consens F, Zucker RA. Alcohol Clin Exp Res. 2008 Aug; 32(8):1429-38. Epub 2008 Jun 6.
Cellular and behavioral interactions of gabapentin with alcohol dependence. [J Neurosci. 2008]
Cellular and behavioral interactions of gabapentin with alcohol dependence.
Roberto M, Gilpin NW, O'Dell LE, Cruz MT, Morse AC, Siggins GR, Koob GF. J Neurosci. 2008 May 28; 28(22):5762-71.
Review Glutamatergic substrates of drug addiction and alcoholism. [Biochem Pharmacol. 2008]
Review Glutamatergic substrates of drug addiction and alcoholism.
Gass JT, Olive MF. Biochem Pharmacol. 2008 Jan 1; 75(1):218-65. Epub 2007 Jun 30.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A randomized, open-label, controlled trial of gabapentin and phenobarbital in th...
A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal.
Am J Addict. 2006 Jan-Feb ;15(1):76-84.

PubMed
HIV/AIDS knowledge and condom use among Somali and Sudanese immigrants in Denmar...
HIV/AIDS knowledge and condom use among Somali and Sudanese immigrants in Denmark.
Scand J Public Health. 2006 ;34(1):92-9.

PubMed
The metabolic syndrome and cardiovascular disease.
The metabolic syndrome and cardiovascular disease.
Ann Med. 2006 ;38(1):64-80.

PubMed
First-trimester pregnancy termination with 800 microg of vaginal misoprostol eve...
First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
Eur J Contracept Reprod Health Care. 2005 Dec ;10(4):249-54.

PubMed
Cross-sectional correlates of serum heat shock protein 70 in the community.
Cross-sectional correlates of serum heat shock protein 70 in the community.
Am J Hypertens. 2006 Feb ;19(2):227-31; discussion 232-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: